Ispire reports Q2 revenue of USD 20.3 million, down 51%

Reuters
Feb 06
Ispire reports <a href="https://laohu8.com/S/QTWO">Q2</a> revenue of USD 20.3 million, down 51%

Ispire Technology Inc. reported financial results for the second quarter (Q2) of fiscal 2026, with revenue of USD 20.3 million. Gross profit for the period was USD 3.5 million. Net loss attributable to shareholders was USD 2.7 million, or USD 0.05 per basic and diluted share, for Q2 fiscal 2026. As of December 31, 2025, Ispire held cash of USD 17.6 million and reported working capital of USD 3.5 million. The company noted a 19 percent reduction in net accounts receivable since June 30, 2025, as a result of ongoing efforts to improve collections. Ispire continues to focus on its vaping technology and precision dosing business, highlighting efforts to market its Ispire ONE device and ongoing initiatives to support product safety and customer benefits.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ispire Technology Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY80874) on February 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10